Tuesday, March 08, 2022 10:04:12 AM
Omicron: BA2, Alarming new study shows BA2 may lead to '27x increase in vaccine-breakthrough capabilities': '30% more capable' to escape vaccines. 4.2x more contagious than Delta—20x more infectious than original strain & has 28
Chris Turnbull
https://twitter.com/search?q=ba2&src=typed_query
ps. for some reason could not copy his only tweet...
Pps.DLR Tweet also...
Chris Turnbull
https://twitter.com/search?q=ba2&src=typed_query
ps. for some reason could not copy his only tweet...
Pps.DLR Tweet also...
💥 thread detailing how new #BA2 subvariant is pounding parts of the 🌍 again—mainly Hong Kong + now GB. Many of the these thematic COVID junior plays have been left for dead, but opportunity it still there—even if peak "COVID" in the public consciousness has passed. $RVVTF $THRM https://t.co/ayZuDsUBbr
— TDR (@TheDalesReport) March 8, 2022
Recent RVVTF News
- Revive Therapeutics Announces Strategic Expansion of Bucillamine Program Across Infectious Diseases, Defence and Biothreat Medical Countermeasures • ACCESS Newswire • 05/20/2026 11:45:00 AM
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
